HCID 22647982、化合物 → 7-(1-tert-Butyl-1,2,3,6-tetrahydropyridin-4-yl)-5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-1,6-naphthyridin-2(1H)-one
反応式
Br[C:2]1[CH:11]=[C:10]2[C:5]([CH:6]=[CH:7][C:8](=[O:20])[N:9]2[C:12]2[C:17]([Cl:18])=[CH:16][CH:15]=[CH:14][C:13]=2[Cl:19])=[C:4]([C:21]2[CH:26]=[CH:25][CH:24]=[CH:23][C:22]=2[Cl:27])[N:3]=1.[C:28]([N:32]1[CH2:37][CH:36]=[C:35]([Sn](C)(C)C)[CH2:34][CH2:33]1)([CH3:31])([CH3:30])[CH3:29]>O1CCOCC1>[C:28]([N:32]1[CH2:33][CH:34]=[C:35]([C:2]2[CH:11]=[C:10]3[C:5]([CH:6]=[CH:7][C:8](=[O:20])[N:9]3[C:12]3[C:17]([Cl:18])=[CH:16][CH:15]=[CH:14][C:13]=3[Cl:19])=[C:4]([C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][C:22]=3[Cl:27])[N:3]=2)[CH2:36][CH2:37]1)([CH3:31])([CH3:30])[CH3:29]参加物
実験手順
A mixture of 100 mg of 7-bromo-5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-1,6-naphthyridin-2(1H)-one (COMPOUND HHH2) and 94 mg of 1-tert-butyl-4-(trimethylstannyl)-1,2,3,6-tetrahydropyridine (COMPOUND PPA-2) in 2 mL of dry dioxane was evacuated and purged three times with Ar. Pd(Ph3P)4 (23 mg) was added and the mixture was evacuated and purged again with Ar. The mixture was heated to reflux and stirred at this temperature overnight, then filtered through Celite and concentrated. The residue was purified by preparative thin-layer chromatography, eluting with 95:5 CH2Cl2-2M NH3 in MeOH, to yield the title compound. The HCl salt was prepared by dissolving this compound in CH2Cl2, adding 1 eq 1M HCl in Et2O, and concentrating. Mass spectrum (ESI) 540 (M+1).
後処理
- customwas evacuated
- custompurged three times with Ar
- additionPd(Ph3P)4 (23 mg) was added
- customthe mixture was evacuated
- custompurged again with Ar
- temperatureThe mixture was heated
- temperatureto reflux
- filtrationfiltered through Celite
- concentrationconcentrated
- customThe residue was purified by preparative thin-layer chromatography
- washeluting with 95:5 CH2Cl2-2M NH3 in MeOH
出典と根拠
- ORDレコード
- ord-56273d3c03404e39ab06bbe436741f17
- 出典データセット
- uspto-grants-2004_10
- 特許番号
- US06809199B2
反応ノート
読み込み中…